Woodline Partners LP
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1784547
San Francisco, CA
Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$622,514
-$93,771 QoQ
Shares Held
266,032
-49.9% QoQ
Ownership
0.371%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $622,514 | 266,032 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $716,285 | 530,582 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $801,178 | 530,582 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $615,475 | 530,582 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $843,625 | 530,582 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,607,663 | 530,582 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,883,437 | 1,055,282 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,204,844 | 1,517,077 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,647,529 | 1,437,026 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,263,827 | 1,403,553 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,060,000 | 1,000,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,889,216 | 1,094,974 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,247,477 | 2,165,551 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,950,892 | 146,519 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,925,720 | 319,747 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,093,743 | 181,272 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,880,112 | 40,748 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $30,948,622 | 368,173 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,842,924 | 507,847 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $26,901,910 | 505,675 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,255,145 | 144,161 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,271,600 | 140,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,507,427 | 137,884 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,099,722 | 43,726 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||